1-3 of 3
Gordon H Sun, MD MS
Close
Sort by
Journal Articles

Healthcare Resource Utilization and Costs Among Patients with Myelodysplastic Syndrome Who Failed 1 st -Line Therapy

Christopher R. Cogle, MD, Sudipto Mukherjee, MD MPH, Tanya GK Bentley, PhD, Michael S Broder, MD MSHS, Eunice Chang, PhD, Moira E. Lawrence, PhD, Thomas J. McKearn, MD PhD, Scott Megaffin, Rita Percy, Michael E. Petrone, MD MPH, Gordon H Sun, MD MS
Journal: Blood
Blood (2014) 124 (21): 2627.
https://doi.org/10.1182/blood.V124.21.2627.2627
Published: 2014
Journal Articles

Treatment Patterns Among Patients with Myelodysplastic Syndromes: Observations of 1 st -Line Therapy, Discontinuation and the Need of Additional Therapies

Sudipto Mukherjee, MD MPH, Christopher R. Cogle, MD, Tanya GK Bentley, PhD, Michael S Broder, MD MSHS, Eunice Chang, PhD, Moira E. Lawrence, PhD, Thomas J. McKearn, MD PhD, Scott Megaffin, Rita Percy, Michael E. Petrone, MD MPH, Gordon H Sun, MD MS
Journal: Blood
Blood (2014) 124 (21): 2598.
https://doi.org/10.1182/blood.V124.21.2598.2598
Published: 2014
Journal Articles

Incidence of First-Line and Second-Line Myelodysplastic Syndrome in a US Commercial Claims Database

Christopher R. Cogle, MD, Sandra E. Kurtin, RN, MS, AOCN, ANP-C, Tanya GK Bentley, PhD, Michael S Broder, MD MSHS, Eunice Chang, PhD, Moira E. Lawrence, PhD, Thomas J. McKearn, MD PhD, Scott Megaffin, Rita Percy, Michael E. Petrone, MD MPH, Gordon H Sun, MD MS
Journal: Blood
Blood (2014) 124 (21): 6008.
https://doi.org/10.1182/blood.V124.21.6008.6008
Published: 2014